Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 1:06 pm Purchase |
2024-09-30 | 13G | TELA Bio, Inc. TELA |
Laurence W. Lytton | 2,452,257 9.900% |
1,112,205 (+83.00%) |
Filing History |
| 2024-11-14 1:05 pm Sale |
2024-09-30 | 13G | CalciMedica, Inc. CALC |
Laurence W. Lytton | 468,943 4.400% |
-287,237 (-37.99%) |
Filing History |
| 2024-11-14 1:03 pm Purchase |
2024-09-30 | 13G | Acutus Medical, Inc. AFIB |
Laurence W. Lytton | 2,078,030 7.000% |
331,207 (+18.96%) |
Filing History |
| 2024-11-14 12:59 pm Sale |
2024-09-30 | 13G | Duos Technologies Group, Inc. DUOT |
Laurence W. Lytton | 400,568 5.200% |
-82,408 (-17.06%) |
Filing History |
| 2024-11-14 12:56 pm Sale |
2024-09-30 | 13G | Azitra, Inc. AZTR |
Laurence W. Lytton | 0 0.000% |
-55,553 (Position Closed) |
Filing History |
| 2024-10-23 7:40 pm Sale |
2024-09-30 | 13G | Creative Realities, Inc. CREX |
Laurence W. Lytton | 784,000 7.500% |
-268,204 (-25.49%) |
Filing History |
| 2024-10-23 7:39 pm Purchase |
2023-12-31 | 13G | Creative Realities, Inc. CREX |
Laurence W. Lytton | 1,052,204 10.100% |
11,000 (+1.06%) |
Filing History |
| 2024-10-23 7:38 pm Purchase |
2023-12-04 | 13G | Creative Realities, Inc. CREX |
Laurence W. Lytton | 1,041,204 10.000% |
41,204 (+4.12%) |
Filing History |
| 2024-10-23 7:37 pm Purchase |
2023-08-18 | 13G | Creative Realities, Inc. CREX |
Laurence W. Lytton | 1,000,000 9.600% |
1,000,000 (New Position) |
Filing History |
| 2024-10-04 5:14 pm Purchase |
2024-09-26 | 13G | MDxHealth SA MDXH |
Laurence W. Lytton | 2,890,595 6.100% |
2,890,595 (New Position) |
Filing History |
| 2024-07-22 3:20 pm Purchase |
2024-07-10 | 13G | TELA Bio, Inc. TELA |
Laurence W. Lytton | 1,340,052 5.400% |
1,340,052 (New Position) |
Filing History |
| 2024-07-08 12:48 pm Purchase |
2024-06-27 | 13G | CalciMedica, Inc. CALC |
Laurence W. Lytton | 756,180 6.900% |
756,180 (New Position) |
Filing History |
| 2024-05-17 5:20 pm Purchase |
2024-05-09 | 13G | Acutus Medical, Inc. AFIB |
Laurence W. Lytton | 1,746,823 5.900% |
1,746,823 (New Position) |
Filing History |
| 2024-04-29 2:34 pm Purchase |
2024-04-17 | 13G | scPharmaceuticals Inc. SCPH |
Laurence W. Lytton | 1,825,234 5.100% |
1,825,234 (New Position) |
Filing History |
| 2024-03-20 1:00 pm Purchase |
2024-02-20 | 13G | Biofrontera Inc. BFRI |
Laurence W. Lytton | 508,886 9.990% |
508,886 (New Position) |
Filing History |
| 2024-03-13 1:32 pm Purchase |
2024-02-09 | 13G | Evoke Pharma, Inc. EVOK |
Laurence W. Lytton | 71,610 9.990% |
71,610 (New Position) |
Filing History |
| 2024-02-27 2:05 pm Purchase |
2024-02-14 | 13G | Azitra, Inc. AZTR |
Laurence W. Lytton | 55,553 5.800% |
55,553 (New Position) |
Filing History |
| 2024-02-14 6:48 pm Sale |
2023-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP |
Laurence W. Lytton | 11,900 0.100% |
-113,129 (-90.48%) |
Filing History |
| 2024-02-14 3:28 pm Purchase |
2023-12-31 | 13G | Scientific Industries, Inc. SCND |
Laurence W. Lytton | 1,083,899 9.990% |
689,220 (+174.63%) |
Filing History |
| 2024-02-14 3:23 pm Purchase |
2023-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Laurence W. Lytton | 3,280,178 9.990% |
1,395,105 (+74.01%) |
Filing History |